WHO Model Prescribing Information: Drugs Used in Skin Diseases
(1997; 132 pages) [French] [Spanish] Ver el documento en el formato PDF
Índice de contenido
Ver el documentoPreface
Ver el documentoIntroduction
Abrir esta carpeta y ver su contenidoParasitic infections
Abrir esta carpeta y ver su contenidoInsect and arachnid bites and stings
Abrir esta carpeta y ver su contenidoSuperficial fungal infections
Abrir esta carpeta y ver su contenidoSubcutaneous fungal infections
Abrir esta carpeta y ver su contenidoBacterial infections
Abrir esta carpeta y ver su contenidoViral infections
Abrir esta carpeta y ver su contenidoEczematous diseases
Abrir esta carpeta y ver su contenidoScaling diseases
Abrir esta carpeta y ver su contenidoPapulosquamous diseases
Ver el documentoCutaneous reactions to drugs
Abrir esta carpeta y ver su contenidoPigmentary disorders
Abrir esta carpeta y ver su contenidoPremalignant lesions and malignant tumours
Abrir esta carpeta y ver su contenidoPhotodermatoses
Abrir esta carpeta y ver su contenidoBullous dermatoses
Ver el documentoAlopecia areata
Ver el documentoUrticaria
Abrir esta carpeta y ver su contenidoConditions common in children
Ver el documentoAcne vulgaris
Ver el documentoPruritus
Ver el documentoTropical ulcers
Abrir esta carpeta y ver su contenidoAntimicrobial drugs
Abrir esta carpeta y ver su contenidoAntifugal drugs
Abrir esta carpeta y ver su contenidoAntiseptic agents
Abrir esta carpeta y ver su contenidoKeratoplastic and keratolytic agents
Cerrar esta carpetaScabicides and pediculicides
Ver el documentoBenzyl benzoate
Ver el documentoLindane
Ver el documentoPermethrin
Abrir esta carpeta y ver su contenidoAnti-inflammatory and antipruritic drugs1
Abrir esta carpeta y ver su contenidoAntiallergics and drugs used in anaphylaxis
Abrir esta carpeta y ver su contenidoUltraviolet radiation-blocking agents (sunscreens)
Abrir esta carpeta y ver su contenidoMiscellaneous drugs
Abrir esta carpeta y ver su contenidoAnnex
Ver el documentoSelected WHO Publications of Related Interest
Ver el documentoBack cover
 

Benzyl benzoate

Lotion, 25%

General information

Benzyl benzoate is a synthetic compound that is produced from benzoic acid and benzyl alcohol. It is toxic to the ectoparasites Sarcoptes scabiei hominis, Pediculus humanus capitis, P. humanus corporis and Pthirus pubis.

Clinical information

Uses

Treatment of scabies and pediculosis of the head, body and pubic area.

Dosage and administration

All doses are suitable for adults and children.

Scabies:

The lotion should be applied to all skin surfaces, from the scalp to the soles of the feet. Care should be taken to avoid contact with the eyes. It is not necessary to bathe before application. To prevent reinfestation, clothing and bedding should be washed or left outside exposed to the air for 72 hours. The lotion is usually applied once daily at night on 2 consecutive days. This may be followed by a single application at night 3 days later.

All members of the household should be treated simultaneously.

Pediculosis:

The lotion should be applied to the affected area and left for 24 hours before being rinsed off. If necessary, treatment may be repeated after 7 and 14 days.

Contacts should also be treated at the some time.

Contraindications

Known hypersensitivity to benzyl benzoate.

Precautions

Benzyl benzoate should not be applied to acutely inflamed or broken skin.

Use in pregnancy

Benzyl benzoate may be applied safely during pregnancy.

Adverse effects

Irritation of the skin with burning or stinging sensations is common.

Overdosage

Gastric lavage may be of value if undertaken within a few hours of accidental ingestion. If convulsions occur they should be treated with intravenous diazepam. Treatment is otherwise supportive.

Storage

Lotion should be stored in well-closed containers, protected from light.

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 24 abril 2012